Cargando…

Beta-cell Insufficiency

‘Beta-cell failure’ is a frequently used term to describe the structural and functional inability of the cells to fulfil their metabolic responsibility. This editorial reviews the anatomy and physiology of the beta cell, and describes factors which regulate this. The authors focus on semantics, comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalra, Sanjay, Gupta, Yashdeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Touch Medical Media 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813463/
https://www.ncbi.nlm.nih.gov/pubmed/29632606
http://dx.doi.org/10.17925/EE.2017.13.02.51
_version_ 1783300201972236288
author Kalra, Sanjay
Gupta, Yashdeep
author_facet Kalra, Sanjay
Gupta, Yashdeep
author_sort Kalra, Sanjay
collection PubMed
description ‘Beta-cell failure’ is a frequently used term to describe the structural and functional inability of the cells to fulfil their metabolic responsibility. This editorial reviews the anatomy and physiology of the beta cell, and describes factors which regulate this. The authors focus on semantics, comparing the phrases ‘beta-cell failure’, ‘functional mass’, and ‘beta-cell insufficiency’. They suggest the use of ‘beta-cell insufficiency’, with descriptors such as ‘partial’ and ‘complete’, or ‘reversible’ and ‘irreversible’, to convey betacell dysfunction in type 2 diabetes. A three-phase taxonomic structure: beta-cell sufficiency, partial/reversible beta-cell insufficiency and complete/irreversible beta-cell insufficiency, is proposed as a tool to understand pathophysiology and facilitate therapeutic decision-making.
format Online
Article
Text
id pubmed-5813463
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Touch Medical Media
record_format MEDLINE/PubMed
spelling pubmed-58134632018-04-09 Beta-cell Insufficiency Kalra, Sanjay Gupta, Yashdeep Eur Endocrinol Pathogenesis of Type 2 Diabetes ‘Beta-cell failure’ is a frequently used term to describe the structural and functional inability of the cells to fulfil their metabolic responsibility. This editorial reviews the anatomy and physiology of the beta cell, and describes factors which regulate this. The authors focus on semantics, comparing the phrases ‘beta-cell failure’, ‘functional mass’, and ‘beta-cell insufficiency’. They suggest the use of ‘beta-cell insufficiency’, with descriptors such as ‘partial’ and ‘complete’, or ‘reversible’ and ‘irreversible’, to convey betacell dysfunction in type 2 diabetes. A three-phase taxonomic structure: beta-cell sufficiency, partial/reversible beta-cell insufficiency and complete/irreversible beta-cell insufficiency, is proposed as a tool to understand pathophysiology and facilitate therapeutic decision-making. Touch Medical Media 2017-08 2017-08-22 /pmc/articles/PMC5813463/ /pubmed/29632606 http://dx.doi.org/10.17925/EE.2017.13.02.51 Text en © Touch Medical Media 2017 http://creativecommons.org/licenses/by-nc/3.0/ This article is published under the Creative Commons Attribution Noncommercial License, which permits any non-commercial use, distribution, adaptation and reproduction provided the original author(s) and source are given appropriate credit. © The Author(s) 2017 Authorship: All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship of this manuscript, take responsibility for the integrity of the work as a whole, and have given final approval to the version to be published.
spellingShingle Pathogenesis of Type 2 Diabetes
Kalra, Sanjay
Gupta, Yashdeep
Beta-cell Insufficiency
title Beta-cell Insufficiency
title_full Beta-cell Insufficiency
title_fullStr Beta-cell Insufficiency
title_full_unstemmed Beta-cell Insufficiency
title_short Beta-cell Insufficiency
title_sort beta-cell insufficiency
topic Pathogenesis of Type 2 Diabetes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813463/
https://www.ncbi.nlm.nih.gov/pubmed/29632606
http://dx.doi.org/10.17925/EE.2017.13.02.51
work_keys_str_mv AT kalrasanjay betacellinsufficiency
AT guptayashdeep betacellinsufficiency